LS, G., MBN, G., B, H., MB, C., FK, K., JJ, H., & MM, R. (2018). Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents. Peptides, 100, 173. https://doi.org/10.1016/j.peptides.2017.11.021
Chicago Style (17th ed.) CitationLS, Gasbjerg, Gabe MBN, Hartmann B, Christensen MB, Knop FK, Holst JJ, and Rosenkilde MM. "Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Antagonists as Anti-diabetic Agents." Peptides 100 (2018): 173. https://doi.org/10.1016/j.peptides.2017.11.021.
MLA (9th ed.) CitationLS, Gasbjerg, et al. "Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Antagonists as Anti-diabetic Agents." Peptides, vol. 100, 2018, p. 173, https://doi.org/10.1016/j.peptides.2017.11.021.